Er Therapeutics Inc PNGM:Over The Counter Market

Last Price$0.0001Over The Counter Market Previous Close - Last Trade as of 12:53PM ET 11/19/21

Today's Change0.00(0.00%)
Bid (Size)$0.0001 (2,200,000)
Ask (Size)$0.0068 (10,000)
Day Low / High$0.0001 - 0.0001
Volume8.0 K
 

View Other Metals/Minerals IndustryPeer Comparison as of 11/19/2021

 

Er Therapeutics Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 8.0 K
12:53PM ET 11/19/2021
 
 

Tamerlane Ventures Inc ( OTC )

Price: $0.0003
Change: 0.00 (0.00%)
Volume: 592.8 K
11:12AM ET 9/16/2021
 
 

Blue Star Global Inc ( OTC )

Price: $0.01
Change: 0.00 (0.00%)
Volume: 525.00
1:50PM ET 8/24/2021
 
 

Petlife Pharmaceuticals Inc ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 95.00
3:16PM ET 11/24/2021
 
 

Universal Potash Corp ( OTC )

Price: $0.0001
Change: 0.00 (0.00%)
Volume: 6.0 K
10:17AM ET 10/27/2021
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionPengram Corp. engages in the acquisition, exploration and development of zinc, lead, vanadium, and galena. It also deals with the exploration of gold properties. The company was founded on April 28, 2006 and is headquartered in Bellingham, WA. View company web site for more details
Address1200 Dupont Street
Bellingham, Washington 98225
Phone+1.360.255.3436
Number of EmployeesN/A
President & Chief Executive OfficerRichard W. Donaldson
Legal CounselStephen F. X. O'Neill

Company Highlights

Price Open$0.0001
Previous Close$0.0001
52 Week Range$0.0001 - 0.009
Market Capitalization$5.8 K
Shares Outstanding58.3 M
SectorNon-Energy Minerals
IndustryOther Metals/Minerals
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.01
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity163.00%